JNJ

7 Upcoming Biotech Catalysts For Year-End 2012 And Early 2013
Seeking Alpha
Fri, 12/7/12 - 11:45 am
Alexza
BiogenIdec
Celsion
Celgene
Sanofi
JNJ
Threshold Pharmaceuticals
Johnson & Johnson files for approval to market Stelara for psoriatic arthritis in US and EU
Yahoo/AP
Thu, 12/6/12 - 11:51 am
psoriatic arthritis
JNJ
Stelara
Do Oxtellar and Trokendi Make Supernus a Buy?
Motley Fool
Wed, 12/5/12 - 12:06 pm
Oxtellar
Trokendi
Supernus Pharmaceuticals
JNJ
Novartis
Johnson & Johnson One-Ups Tuberculosis
Motley Fool
Sun, 12/2/12 - 12:05 pm
JNJ
tuberculosis
bedaquiline
A Winning Long-Term Growth Pick
Motley Fool
Sat, 12/1/12 - 09:53 am
JNJ
J&J Wins Reversal of $1.1 Million Levaquin Punitive Award
Bloomberg
Fri, 11/30/12 - 04:00 pm
JNJ
Levaquin
Celgene, NPS Pharmaceuticals, Amarin, J&J, Medivation Among Stocks to Watch in December
Minyanville
Fri, 11/30/12 - 04:28 pm
NPS Pharmaceuticals
Medivation
JNJ
Celgene
Amarin
J&J CEO Gorsky elected chairman, replacing Weldon
Reuters
Fri, 11/30/12 - 09:41 am
JNJ
Pharma CEOs
William Weldon
Alex Gorsky
J&J says won't enforce AIDS drug patent in Africa
Reuters
Thu, 11/29/12 - 11:04 am
AIDS
JNJ
Africa
patents
Prezista
FDA advisory panel backs J&J TB drug
Reuters
Thu, 11/29/12 - 10:38 am
JNJ
FDA
advisory panels
tuberculosis
bedaquiline
GSK and J&J lead rivals in drug access for poor
Reuters
Wed, 11/28/12 - 10:18 am
JNJ
GSK
J&J preps case for quick FDA approval of new TB drug
Fierce Biotech
Mon, 11/26/12 - 12:21 pm
JNJ
FDA
tuberculosis
bedaquiline
This Healthcare Giant Needs to Focus on Organic Growth
Motley Fool
Wed, 11/21/12 - 11:21 am
JNJ
J&J, Lilly, Merck plan clinical trial site database
Reuters
Thu, 11/15/12 - 11:13 am
JNJ
Eli Lilly
Merck
clinical trials
Teva Is Still Healthier Than Its Big Pharma Peers
Seeking Alpha
Thu, 11/15/12 - 10:47 am
Teva
AstraZeneca
Bristol-Myers Squibb
GSK
JNJ
Merck
Novo Nordisk
Novartis
Pfizer
Sanofi
Who Will Pioneer the New Diabetes Market?
Motley Fool
Thu, 11/15/12 - 10:45 am
diabetes
JNJ
Merck
Bristol-Myers Squibb
AstraZeneca
SGLT2 inhibitor
Can You Profit From 4 Big Pharmas Making Headlines?
Motley Fool
Wed, 11/14/12 - 11:30 am
Abbott Labs
JNJ
Merck
Pfizer
Prostate Cancer Market Takes Shape - Part 1: Dendreon And Medivation
Seeking Alpha
Wed, 11/14/12 - 10:33 am
prostate cancer
Medivation
Dendreon
Provenge
JNJ
Sanofi
Zytiga, Xtandi will help pump prostate cancer market to $9.1B
Fierce Pharma
Tue, 11/13/12 - 05:45 pm
Xtandi
Zytiga
prostate cancer
JNJ
Medivation
Astellas
J&J Ponders Elan Tie While Alzheimer Drug Future Reviewed
Bloomberg
Tue, 11/13/12 - 11:43 am
Elan
JNJ
Alzheimer's disease
bapineuzumab

Pages